Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy
Jifeng Yu, Bangguo Zhou, Shen Zhang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Exploring treatment options in cancer: Tumor treatment strategies
Beilei Liu, Hongyu Zhou, Licheng Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 175
Probiotics, prebiotics, and postbiotics in health and disease
Jing Ji, Weilin Jin, Shuang‐Jiang Liu, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 144
Bioactive Layered Double Hydroxides for Synergistic Sonodynamic/Cuproptosis Anticancer Therapy with Elicitation of the Immune Response
Wei Tang, Jie Wu, Li Wang, et al.
ACS Nano (2024) Vol. 18, Iss. 15, pp. 10495-10508
Closed Access | Times Cited: 38
Advances and applications of nanoparticles in cancer therapy
Xianzhou Huang, Tao He, Xiuqi Liang, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 26
Lysosomal Rupture‐Mediated “Broken Window Effect” to Amplify Cuproptosis and Pyroptosis for High‐Efficiency Cancer Immunotherapy
Guo‐Qing Zhu, Man Wang, Luying Qiao, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 29
Closed Access | Times Cited: 23
Nanotechnology Reprogramming Metabolism for Enhanced Tumor Immunotherapy
Yangkai Zhou, Jing Yuan, Ke Xu, et al.
ACS Nano (2024) Vol. 18, Iss. 3, pp. 1846-1864
Closed Access | Times Cited: 21
Engineered Nanomaterials to Potentiate CRISPR/Cas9 Gene Editing for Cancer Therapy
Ke Yi, Huimin Kong, Yeh‐Hsing Lao, et al.
Advanced Materials (2023) Vol. 36, Iss. 13
Closed Access | Times Cited: 27
Nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment
Shiyao Zhou, Yingjie Li, Qinjie Wu, et al.
MedComm – Biomaterials and Applications (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 10
Gut microbiota and dietary intervention: affecting immunotherapy efficacy in non–small cell lung cancer
Yu Xin, Chenguang Liu, Dan Zang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Single-cell encapsulation systems for probiotic delivery: Armor probiotics
Runan Zhao, Ting Yu, Jiaheng Li, et al.
Advances in Colloid and Interface Science (2024) Vol. 332, pp. 103270-103270
Closed Access | Times Cited: 10
CRISPR–Cas9 delivery strategies for the modulation of immune and non-immune cells
Shahad K. Alsaiari, Behnaz Eshaghi, Bujie Du, et al.
Nature Reviews Materials (2024)
Closed Access | Times Cited: 10
Ultrasound-triggered and glycosylation inhibition-enhanced tumor piezocatalytic immunotherapy
Yinying Pu, Bangguo Zhou, Jinhong Bing, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Nature Inspired Delivery Vehicles for CRISPR‐Based Genome Editing
Elizabeth Maria Clarissa, Mamata Karmacharya, Hyun‐Min Choi, et al.
Small (2025)
Closed Access | Times Cited: 1
Enhancing CRISPR/Cas systems with nanotechnology
Rupali Chowdhry, Steven Z. Lu, Seungheon Lee, et al.
Trends in biotechnology (2023) Vol. 41, Iss. 12, pp. 1549-1564
Closed Access | Times Cited: 21
Targeted protein delivery based on stimuli‐triggered nanomedicine
Jinzhao Liu, Yang Zhou, Qingyang Lyu, et al.
Exploration (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 19
The emergence of cancer sono-immunotherapy
Yuqi Yang, Yuan Cheng, Liang Cheng
Trends in Immunology (2024) Vol. 45, Iss. 7, pp. 549-563
Closed Access | Times Cited: 8
Exploring Therapeutic Advances: A Comprehensive Review of Intestinal Microbiota Modulators
Lara Pires, Ana M. Gonzaléz‐Paramás, Sandrina A. Heleno, et al.
Antibiotics (2024) Vol. 13, Iss. 8, pp. 720-720
Open Access | Times Cited: 7
Bacterial nanotechnology as a paradigm in targeted cancer therapeutic delivery and immunotherapy
Ahmad Gholami, Milad Mohkam, Saeede Soleimanian, et al.
Microsystems & Nanoengineering (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Influence of gut and lung dysbiosis on lung cancer progression and their modulation as promising therapeutic targets: a comprehensive review
Rajan Thapa, A Magar, Jesus Shrestha, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 7
Ultrasound-induced immune responses in tumors: A systematic review and meta-analysis
Anne Rix, Helen Heinrichs, Céline Porte, et al.
Journal of Controlled Release (2024) Vol. 371, pp. 146-157
Open Access | Times Cited: 6
Oxygen‐Independent Synchronized ROS Generation and Hypoxia Prodrug Activation with Z‐Scheme Heterostructure Sonosensitizer
Yi-Ning Chen, Tianshu Zou, Gaoying Xin, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 16
Insights of probiotics as an alternative medicine for cancer therapy, mechanism, and applications
Sourik Mukherjee, Dharmender Kumar, Dipanjan Guha
Medicine in Microecology (2024) Vol. 22, pp. 100111-100111
Open Access | Times Cited: 5
Photosynthetic Bacteria‐Hitchhiking 2D iMXene‐mRNA Vaccine to Enable Photo‐Immunogene Cancer Therapy
Shen Zhang, Jifeng Yu, Yunyun Liu, et al.
Advanced Science (2024) Vol. 11, Iss. 28
Open Access | Times Cited: 4
On‐Demand Peroxynitrite Overproduction Reprograms Systemic Immune Function for Augmented Sono‐Immunotherapy against Tumor
Luping Qiu, Jing Liang, Liyun Xue, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 48
Closed Access | Times Cited: 4
Spatiotemporal Delivery of Dual Nanobodies by Engineered Probiotics to Reverse Tumor Immunosuppression via Targeting Tumor-Derived Exosomes
Shurong Qin, Yuta Liu, Guanzhong He, et al.
ACS Nano (2024) Vol. 18, Iss. 39, pp. 26858-26871
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top